Investor
Abingworth
VC firm
Key details
- Profile type
- Organization
- Geography
- London, Unknown / Other, UK
- Stage
- 3. Early Revenue, 4. Scaling, 5. Growth, 6. Pre-IPO
- Sector
- health, biotech, therapeutic, biomarker, bioimaging, CGT, lifesciences, pharma, pharmaceuticals, mRNA, transcriptomics, cannabis, psychedelic, therapy, drugs, gene therapy, diagnostics, protein, cell therapy, biopharma, metabolomics, medical device, IVD, biomarkers, lifescience, life-science, life sciences, psychedelics, bio, life sciences tools, genomics, life science, CBD, drug, proteomics, medicines, medtech, metabolites, in vitro diagnostics, therapeutics, med device, medical devices
- Invests in
- ["Canada","Denmark","France","Germany","Ireland","Norway","Sweden","Switzerland","Netherlands","Togo","UK","USA"]
- Investment size
- $15M to $30M
- Founder groups
- Not publicly stated
Official source
TorontoStarts does not endorse or rank this record. Confirm current details with the official source.